Search Login Register

Vipoma (WDHA) Summary

Description: A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.

Also Known As: WDHA; Syndrome, Vipoma; Diarrheogenic Islet Cell Tumor; Pancreatic VIPoma; VIP-Secreting Tumor (VIPoma) Show All >>

Networked: 235 relevant articles (12 outcomes, 13 trials/studies) for this Disease

Key Drugs and Agents for Vipoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Octreotide (Sandostatin) : 9 outcomes 1 study in 44 results : FDA 14 Generic
  2. Somatostatin (Somatotropin Release-Inhibiting Factor) : 4 outcomes 2 studies in 39 results : IBA
  3. Hormones : 1 outcome 1 study in 13 results : IBA
  4. Calcitonin (Calcitonin, Eel) : 1 outcome in 8 results : FDA 1 Generic
  5. Anti-Bacterial Agents (Antibiotics) : 1 outcome in 1 result : IBA
  6. Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide)) : 5 studies in 85 results : IBA
  7. Serotonin (5 Hydroxytryptamine) : 3 studies in 3 results : IBA
  8. Pancreatic Polypeptide (Pancreatic Polypeptide (PP)) : 2 studies in 14 results : IBA
  9. WDHA syndrome : 1 study in 19 results : IBA
  10. Glucagonoma syndrome : 1 study in 5 results : IBA
Show All >>

Diseases Related to Vipoma

  1. Carcinoid Tumor (Carcinoid)
  2. Neoplasms (Cancer)
  3. Diarrhea
  4. Gastrinoma
  5. Insulinoma
Show All >>

Key Therapies for Vipoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome in 8 results
  2. Liver Transplantation : 4 results
  3. Splenectomy : 3 results
  4. Pancreatectomy : 3 results
  5. Subcutaneous Infusions : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.